1. Sharma B, Bruner A, Barnett G, Fishman M. Opioid use disorders. Child Adolesc Psychiatr Clin N Am. 2016;25(3):473–87.
2. Definition of Addiction [Internet]. American society of addiction medicine. 2019. p. 117–24. Available from: https://www.asam.org/docs/default-source/quality-science/asam’s-2019-definition-of-addiction-(1).pdf?sfvrsn=b8b64fc2_2.
3. Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain. 2007;129(3):235–55.
4. Cathie E. Alderks PD. Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003-2015 [internet]. The CBHSQ Report. Available from: https://www.samhsa.gov/data/sites/default/files/report_3192/ShortReport-3192.html
5. Substance Abuse and Mental Health Services Administration. Medications for opioid use disorder. Treatment Improvement Protocol (TIP) Series 63, Full Document. 2019;(HHS Publication No. (SMA) 19-5063FULLDOC).